Amvia Edge HF-T QP

Optimized therapy. Simplified care.

With a 30% non-response rate to CRT¹ , therapy optimization is essential for clinicians taking care of CRT patients. From the implantation to managing individual patients, accommodating each condition and need is both demanding and time-consuming for healthcare teams.